Professor Steve Rannard

World AIDS Day: Are long-acting HIV therapies the future?

December 1, 2021

Long-acting injectable medicine as potential route to COVID-19 therapy

April 14, 2021

Liverpool launches new Centre of Excellence for Long-acting Therapeutics

January 12, 2021

University and Scott Bader Company Ltd announce joint venture to develop a novel polymer chemistry platform

June 30, 2020

£24m boost for revolutionary long-acting medicine research

January 31, 2020

Novel nano-engineered ‘microneedles’ to help HIV drug delivery

August 19, 2019

University spin out company appoints Executive Chairman

June 10, 2019

£3m boost for Liverpool advanced materials and healthcare research

March 27, 2018

£2.2m collaboration to develop new approaches for HIV therapy

September 15, 2017

New partnership paves way for improved HIV treatments through nanomedicine

December 1, 2015